Paclitaxel by 3-h Infusion and Carboplatin in Anthracycline-resistant Advanced Breast Cancer. A Phase II Study Conducted by the Hellenic Cooperative Oncology Group

By Fountzilas G.   Athanassiadis A.   Kalogera-Fountzila A.   Aravantinos G.   Bafaloukos D.   Briasoulis E.   Dombros N.   Ioannidis I.   Pavlidis N.   Kosmidis P.   Skarlos D.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1893-1895

Elsevier

Access to resources Recommend Favorite

Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines

By Spigel David Robert  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 47-47

Informa Healthcare

Access to resources Recommend Favorite

Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: a phase II study

By Costanzo F.D.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 2, 1999-03 ,pp. : 165-171

Springer Publishing Company

Access to resources Recommend Favorite

Salvage Therapy with Capecitabine Plus Weekly Paclitaxel in Heavily Pretreated Advanced Breast Cancer: A Multicenter Phase II Study

By Bari Mario  

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 307-313

Adis International

Access to resources Recommend Favorite

Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study

By Frasci Giuseppe   Comella Pasquale   D'Aiuto Giuseppe   Budillon Alfredo   Barbarulo Deborah   Thomas Renato   Capasso Immacolata   Casaretti Rossana   Daponte Antonio   Caponigro Francesco   Gravina Adriano   Maiorino Luigi   Caratení Giacomo   Gentile Alfonso   Comella Giuseppe  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 13-26

Springer Publishing Company

Access to resources Recommend Favorite